PRIMECAP MANAGEMENT CO/CA/ - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,305,472
-3.2%
1,094,2000.0%0.01%0.0%
Q2 2023$13,743,152
+7.4%
1,094,200
-5.1%
0.01%0.0%
Q1 2023$12,791,206
-9.2%
1,153,4000.0%0.01%
-15.4%
Q4 2022$14,083,014
+1.6%
1,153,400
-13.2%
0.01%0.0%
Q3 2022$13,866,000
-2.8%
1,328,2000.0%0.01%0.0%
Q2 2022$14,265,000
+5.4%
1,328,200
-7.0%
0.01%
+30.0%
Q1 2022$13,529,000
-23.3%
1,428,600
-6.5%
0.01%
-16.7%
Q4 2021$17,648,000
+13.6%
1,528,000
-6.0%
0.01%
+9.1%
Q3 2021$15,529,000
-12.7%
1,626,100
-11.9%
0.01%
-8.3%
Q2 2021$17,786,000
-15.5%
1,845,000
-13.4%
0.01%
-20.0%
Q1 2021$21,044,000
-57.2%
2,130,0000.0%0.02%
-59.5%
Q4 2020$49,182,000
+63.5%
2,130,0000.0%0.04%
+48.0%
Q3 2020$30,076,000
-6.4%
2,130,0000.0%0.02%
-10.7%
Q2 2020$32,120,000
+53.7%
2,130,000
-5.8%
0.03%
+40.0%
Q1 2020$20,892,000
-6.5%
2,261,000
-1.5%
0.02%
+25.0%
Q4 2019$22,353,000
+26.8%
2,295,000
+4.4%
0.02%
+14.3%
Q3 2019$17,624,0002,197,5000.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 21,719,191$226,748,0008.80%
Perceptive Advisors 27,372,917$285,773,0008.29%
Palo Alto Investors LP 9,847,774$102,811,0008.13%
Finepoint Capital LP 1,688,400$17,627,0005.80%
CM Management, LLC 450,000$4,698,0005.24%
Avoro Capital Advisors LLC 26,800,000$279,792,0005.17%
Artal Group S.A. 4,000,000$41,760,0001.78%
Kynam Capital Management, LP 676,849$7,066,0001.49%
Ghost Tree Capital, LLC 500,000$5,220,0001.46%
Boxer Capital, LLC 2,325,000$24,273,0001.36%
View complete list of AMICUS THERAPEUTICS INC shareholders